Aehr's Q1 Revenue Jumps 200% to $33M; $150M Outlook Backed by FOX-XP Eval and 12+ Prospects
AEHR has more than doubled off its 52-week low of $18.7.
Summary
Aehr's fiscal Q1 2027 revenue hit a record $33 million, up 200% year over year, with $46.7 million in bookings and $0.21 GAAP EPS. Management raised full-year revenue guidance to $150 million, a big step up from the $50 million FY2026 base that followed a 15% decline. The demand story is broadening: the lead AI processor customer is expanding capacity, a major chip supplier plans to buy a FOX-XP burn-in test cell for evaluation in Taiwan with installation set for early 2027, and the potential customer base now spans more than a dozen companies across AI processors, silicon photonics, silicon carbide and gallium nitride. Cash stood at $105.1 million on September 25, 2026, down from $116.5 million on May 29, 2026, so the ramp is consuming some liquidity but the balance sheet remains solid. The FOX-XP evaluation converting to a production order in early 2027 is the next concrete checkpoint for the $150 million target.
At the time of this announcement, AEHR was trading at $58.67 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $18.70 to $147.40. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.